Your email has been successfully added to our mailing list.

×
-0.0357142857142858 -0.0773809523809524 -0.0178571428571429 0.0119047619047619 -0.0714285714285714 -0.166666666666667 -0.146428571428571 -0.184595238095238
Stock impact report

PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent [MarketWatch]

PhaseBio Pharmaceuticals, Inc. (PHAS) 
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am Check Earnings Report
Company Research Source: MarketWatch
PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent Shares of PhaseBio Pharmaceuticals Inc. PHAS, +12.73% more than doubled in premarket trade Monday, soaring 112% toward a record high, after the biopharmaceutical company announced positive phase 1 trial results of PB2452, a reversal agent for the antiplatelet drug ticagrelor. The trial showed that the effects of PB2452 were immediate, with sustained reversal of ticagrelor antiplatelet effects without reports of drug-related serious adverse events. "The data support further evaluation of PB2452 for the reversal of the antiplatelet effects of ticagrelor in emergency situations involving major bleeding and to enable emergent or urgent surgery in patients," said Deepak Bhatt, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital. The company is planning to initiate a phase 2a trial in the first half of this year. The stock, which went public in Oct Show less Read more
Impact Snapshot
Event Time:
PHAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PHAS alerts
Opt-in for
PHAS alerts

from News Quantified
Opt-in for
PHAS alerts

from News Quantified